World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
39955
World Ranking
16382
National Ranking
8242

Overview

David F. Ransohoff is affiliated with the University of North Carolina at Chapel Hill in the United States. Their research primarily focuses on Medicine, with a significant emphasis on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, and Epidemiology.

Their work targets several main topics, including:

  • Colorectal Cancer Screening and Detection
  • Genetic factors in colorectal cancer
  • Gastric Cancer Management and Outcomes
  • Colorectal Cancer Surgical Treatments
  • Healthcare cost, quality, practices
  • Health Systems, Economic Evaluations, Quality of Life
  • Ferroptosis and cancer prognosis

David F. Ransohoff has contributed to multiple research papers, some of which have been published in notable venues. Recent publications include:

  • Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy (2020), published in Cell
  • Integrated Proteomic and Glycoproteomic Characterization of Human High-Grade Serous Ovarian Carcinoma (2020), published in Cell Reports
  • Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer (2020), published in UNC Libraries
  • An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principles (2023), published in Gut
  • Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer (2025), published in Cell

Their frequent co-authors include Thomas F. Imperiale, Steven J. Skates, Christine D. Berg, Christopher R. Kinsinger, and Mehdi Mesri.

Ransohoff's publications appear predominantly in the following venues:

  • UNC Libraries
  • JNCI Journal of the National Cancer Institute
  • Annals of Internal Medicine
  • Cell
  • Gut

Best Publications

  • Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration.

    Karel G.M. Moons;Douglas G. Altman;Johannes B. Reitsma;John P.A. Ioannidis

  • Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications

    Robert H. Riddell;Harvey Goldman;David F. Ransohoff;Henry D. Appelman

  • Problems of Spectrum and Bias in Evaluating the Efficacy of Diagnostic Tests

    David F. Ransohoff;Alvan R. Feinstein

  • Multitarget Stool DNA Testing for Colorectal-Cancer Screening

    Thomas F. Imperiale;David F. Ransohoff;Steven H. Itzkowitz;Theodore R. Levin

  • Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings.

    Thomas F. Imperiale;David R. Wagner;Ching Y. Lin;Gregory N. Larkin

  • Proteogenomic characterization of human colon and rectal cancer

    Bing Zhang;Jing Wang;Xiaojing Wang;Jing Zhu

  • Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.

    Thomas F. Imperiale;David F. Ransohoff;Steven H. Itzkowitz;Barry A. Turnbull

  • Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma

    Terri A. Addona;Susan E. Abbatiello;Birgit Schilling;Steven J. Skates

  • Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer

    Hui Zhang;Tao Liu;Zhen Zhang;Samuel H. Payne

  • Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer

    Timothy Robert Church;Michael Wandell;Catherine Lofton-Day;Steven J Mongin

  • Rules of evidence for cancer molecular-marker discovery and validation

    David F Ransohoff;David F Ransohoff

  • Bias as a threat to the validity of cancer molecular-marker research

    David F. Ransohoff

  • Gastroesophageal reflux, Barrett esophagus, and esophageal cancer. Scientific review

    Nicholas Shaheen;David F. Ransohoff

  • Treatment adherence and risk of death after a myocardial infarction.

    R.I. Horwitz;C.M. Viscoli;R.M. Donaldson;C.J. Murray

  • Nonpolypoid neoplastic lesions of the colorectal mucosa.

    Shin ei Kudo;René Lambert;John I. Allen;Hiroaki Fujii

  • Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities.

    Suhas Vasaikar;Chen Huang;Xiaojing Wang;Vladislav A. Petyuk

  • Addressing overdiagnosis and overtreatment in cancer: a prescription for change

    Laura J Esserman;Ian M Thompson;Brian Reid;Peter Nelson

  • European guidelines for quality assurance in colorectal cancer screening and diagnosis : Overview and introduction to the full Supplement publication.

    L. Von Karsa;J. Patnick;J. Patnick;N. Segnan;W. Atkin

  • Screening for Colorectal Neoplasms With New Fecal Occult Blood Tests: Update on Performance Characteristics

    James E. Allison;Lori C. Sakoda;Theodore R. Levin;Jo P. Tucker

  • Are Physicians Doing Too Much Colonoscopy? A National Survey of Colorectal Surveillance after Polypectomy

    Pauline A. Mysliwiec;Martin L. Brown;Carrie N. Klabunde;David F. Ransohoff

Frequent Co-Authors

Steven A. Carr
Steven A. Carr Broad Institute
daniel c liebler
daniel c liebler Vanderbilt University
Amanda G. Paulovich
Amanda G. Paulovich Fred Hutchinson Cancer Research Center
David L. Tabb
David L. Tabb Stellenbosch University
Michael Pignone
Michael Pignone The University of Texas at Austin
John P. A. Ioannidis
John P. A. Ioannidis Stanford University
Richard D. Smith
Richard D. Smith Pacific Northwest National Laboratory
Christopher J. O'Donnell
Christopher J. O'Donnell Harvard Medical School
Michael Snyder
Michael Snyder Stanford University
Li Ding
Li Ding Washington University in St. Louis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medical careers in the USA doesn’t always start or end with an MD. Many students consider diverse online programs to advance in healthcare, public health, or nursing roles. For those interested in healthcare administration, online mha programs cahme accredited offer flexible learning and leadership skills, making them ideal for professionals aspiring to managerial positions.

Nursing professionals can also benefit from online study. If you’re looking to earn a bachelor’s degree quickly, consider rn to bsn online no clinicals programs, which minimize required in-person training, helping experienced RNs upskill efficiently.

For advanced practice, doctoral options are expanding online. Students seeking a swift transition from MSN to DNP should review the fastest msn to dnp program, offering expedited pathways to top credentials. If flexibility and manageable coursework are priorities, some of the easiest online dnp programs allow working professionals to balance studies with career demands.

These growing online degree choices make healthcare careers and advancement more accessible for diverse student needs and schedules.

Best Scientists Citing David F. Ransohoff

Trending Scientists

Recently Published Articles